Your email has been successfully added to our mailing list.

×
0 0 0 -0.00192648867507661 -0.0421977208659404 -0.104781392513904 -0.0841015705780555 -0.0835573647376385
Stock impact report

Regenxbio GAAP EPS of -$1.30 misses by $0.36, revenue of $30.34M misses by $15.14M [Seeking Alpha]

REGENXBIO Inc. (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
Company Research Source: Seeking Alpha
REGENXBIO expects its balance in cash, cash equivalents and marketable securities of $240.9 million as of December 31, 2025 to fund its operations into early 2027. More on Regenxbio Regenxbio: Cautiously Bullish After FDA Setbacks REGENXBIO: Key FDA Decision On Hunter Syndrome Just Weeks Away REGENXBIO Inc. (RGNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Regenxbio Q4 2025 Earnings Preview Regenxbio dealt win by appeals court in patent spat with Sarepta Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
RGNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RGNX alerts
Opt-in for
RGNX alerts

from News Quantified
Opt-in for
RGNX alerts

from News Quantified